Clinical Outcomes of Large-Bore Aspiration Thrombectomy for Tumor Pulmonary Embolism in Renal Cell Carcinoma
- PMID: 41072964
- PMCID: PMC12516271
- DOI: 10.1016/j.jaccas.2025.105358
Clinical Outcomes of Large-Bore Aspiration Thrombectomy for Tumor Pulmonary Embolism in Renal Cell Carcinoma
Abstract
We present a 4-year longitudinal follow-up of a previously reported case involving a 66-year-old man with renal cell carcinoma who underwent radical nephrectomy, complicated by a massive pulmonary artery tumor embolism treated with large-bore aspiration thrombectomy. Serial clinical evaluations and imaging over 4 years have shown no evidence of disease recurrence following the initial intervention. This case underscores the evolving role of emergent large-bore aspiration thrombectomy in oncologic settings, not only as a therapeutic intervention but also for its diagnostic utility in enabling histopathologic characterization and guiding oncologic management. TAKE-HOME MESSAGES: Large-bore aspiration thrombectomy may offer long-term disease control in cases of tumor pulmonary embolism. This procedure can aid diagnosis and inform oncologic treatment planning through tissue acquisition.
Keywords: cancer; pulmonary circulation; thrombus.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures Dr Gayed has served as a Medtronic consultant and received grant from Bayer Research. The other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
LinkOut - more resources
Full Text Sources
